Sotera Health logo

Sotera HealthNASDAQ: SHC

Profile

Sector:

Healthcare

Country:

United States

IPO:

20 November 2020

Next earnings report:

05 November 2024

Last dividends:

N/A

Next dividends:

N/A
$4.49 B
-41%vs. 3y high
88%vs. sector
113.29
-50%vs. 3y high
91%vs. sector
-29%vs. 3y high
93%vs. sector
-51%vs. 3y high
55%vs. sector

Price

after hours | Fri, 01 Nov 2024 21:16:17 GMT
$15.86+$0.26(+1.67%)

Dividend

No data over the past 3 years
$276.59 M$278.58 M
$276.59 M$8.75 M

Analysts recommendations

Institutional Ownership

SHC Latest News

Sotera Health Announces Dates for Third-Quarter 2024 Earnings Release and November 2024 Investor Day
globenewswire.com22 October 2024 Sentiment: POSITIVE

CLEVELAND, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, today announced its plans to release its financial results for the third-quarter ended September 30, 2024 before the market opens on Tuesday, November 5, 2024. Following the release, management will hold a conference call at 9:00 a.m. Eastern Time to discuss the Company's operating highlights and financial results.

Sotera Health Announces Secondary Offering of Common Stock
globenewswire.com04 September 2024 Sentiment: NEUTRAL

CLEVELAND, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC) (the “Company”) today announced the launch of a secondary offering (the “Offering”) of 25,000,000 shares of its common stock, par value $0.01 per share. All 25,000,000 shares are being offered for sale by certain affiliates of Warburg Pincus LLC (“Warburg Pincus”) and GTCR LLC (“GTCR”) as selling stockholders. No other entities, and no individuals, are selling shares in the Offering. It is expected that, as a result of the Offering, the Company's sponsors (affiliates of Warburg Pincus and GTCR) will cease to own a majority of the Company's outstanding common stock, which will affect certain sponsor rights and related matters. These rights are described in the Company's most recently filed annual general meeting proxy statement. The Company is not offering any shares in the Offering and will not receive any of the proceeds from the Offering. The Company will pay the expenses of the Offering pursuant to its obligations under its Amended and Restated Registration Rights Agreement.

Sotera Health Company (SHC) Q2 2024 Earnings Call Transcript
seekingalpha.com05 August 2024 Sentiment: NEUTRAL

Sotera Health Company (NASDAQ:SHC ) Q2 2024 Earnings Conference Call August 5, 2024 9:00 AM ET Company Participants Jason Peterson - VP & Treasurer Michael Petras - Chairman & CEO Jonathan Lyons - SVP & CFO Conference Call Participants Dave Windley - Jefferies Brett Fishbin - KeyBanc Capital Markets Patrick Donnelly - Citigroup Inc. Casey Woodring - J.P. Morgan Chase Salem Salem - Barclays Jason Bednar - Piper Sandler Michael Polark - Wolfe Research Operator Good morning, and welcome to the Sotera Health Second Quarter 2024 Conference Call.

Sotera Health Company (SHC) Q2 Earnings and Revenues Surpass Estimates
zacks.com05 August 2024 Sentiment: POSITIVE

Sotera Health Company (SHC) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.21 per share a year ago.

Sotera Health Reports Second-Quarter and First-Half 2024 Results
globenewswire.com05 August 2024 Sentiment: POSITIVE

CLEVELAND, Aug. 05, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, today announced financial results for the three and six months ended June 30, 2024.

Sotera Health Appoints Christopher Simon to the Board of Directors
globenewswire.com01 August 2024 Sentiment: POSITIVE

CLEVELAND, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sotera Health Company (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry, announced today it has appointed Christopher Simon as a new independent director to its Board of Directors. Mr. Simon will serve as a member of the Leadership Development and Compensation Committee of the Board of Directors.

The Schall Law Firm Urges Sotera Health Company Investors With Losses Over $100,000 To Establish Communication
accesswire.com29 July 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / July 29, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023.

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication
accesswire.com26 July 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / July 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023.

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication
accesswire.com25 July 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / July 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023.

The Schall Law Firm Encourages Sotera Health Company Investors With Losses Over $100,000 To Establish Communication
accesswire.com24 July 2024 Sentiment: NEGATIVE

LOS ANGELES, CA / ACCESSWIRE / July 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Sotera Health Company ("Sotera" or "the Company") (NASDAQ:SHC) for violations of the federal securities laws. Investors who purchased the Company's shares pursuant and/or traceable to the Company's initial public offering conducted on November 20, 2020 (the "IPO") and/or pursuant and/or traceable to the Company's secondary public offering conducted on or around March 18, 2021 (the "SPO," and together with the IPO, the "Offerings") and/or between November 20, 2020 and September 19, 2022, both dates inclusive (the "Class Period"), are encouraged to contact the firm before March 27, 2023.

What type of business is Sotera Health?

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems. The company also provides microbiological and analytical chemistry testing, as well as technical assistance, regulatory consulting, and advisory services. It serves medical devices, pharmaceuticals, food safety, agricultural products, cancer treatment, and high-performance materials industries, as well as commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

What sector is Sotera Health in?

Sotera Health is in the Healthcare sector

What industry is Sotera Health in?

Sotera Health is in the Diagnostics & Research industry

What country is Sotera Health from?

Sotera Health is headquartered in United States

When did Sotera Health go public?

Sotera Health initial public offering (IPO) was on 20 November 2020

What is Sotera Health website?

https://soterahealth.com

Is Sotera Health in the S&P 500?

No, Sotera Health is not included in the S&P 500 index

Is Sotera Health in the NASDAQ 100?

No, Sotera Health is not included in the NASDAQ 100 index

Is Sotera Health in the Dow Jones?

No, Sotera Health is not included in the Dow Jones index

When was Sotera Health the previous earnings report?

No data

When does Sotera Health earnings report?

The next expected earnings date for Sotera Health is 05 November 2024